Sermorelin vs. Ipamorelin/CJC-1295 vs. Tesamorelin: Which Growth Hormone Peptide Is Right for You?

Growth hormone output declines significantly with age — production can fall by more than half between your 20s and 60s. For many people, that decline shows up as stubborn body fat that won't budge, slower recovery from exercise, poor sleep, and a general sense that the body isn't responding the way it used to.

Peptide therapy is one way to address that decline. But the three most commonly prescribed options — sermorelin, ipamorelin/CJC-1295, and tesamorelin — are not interchangeable versions of the same treatment. Choosing between them should be based on your goals, not whoever marketed their option most aggressively.

What These Peptides Have in Common

None of these are synthetic human growth hormone (HGH). They are growth hormone-releasing hormone analogs that work by signaling your pituitary gland to produce its own GH — naturally, in pulses, through your body's existing feedback loops.

This matters. Synthetic HGH bypasses those feedback mechanisms entirely, which is why it carries risks like insulin resistance and soft tissue overgrowth. These peptides work with your body's regulatory systems, not around them.

All three drive the same downstream process: your pituitary releases GH → your liver produces IGF-1 → IGF-1 drives the benefits you're after: fat metabolism, tissue repair, sleep quality, and body composition improvements. The differences lie in how strongly each peptide stimulates that process, and through what mechanism.

The Three Options

Sermorelin — The Foundation

Sermorelin is the gentlest of the three. It's a fragment of the natural GHRH molecule, has decades of clinical use behind it, and produces a modest, dose-dependent increase in GH output.

Sleep quality is typically the first benefit patients notice, often within two to four weeks. Recovery between training sessions improves. Over three to six months, most patients see gradual improvements in skin elasticity, hair quality, and body composition.

Dosing is simple: one subcutaneous injection daily, typically before bed to align with your body's natural nighttime GH release. Side effects are generally mild — occasional water retention, temporary wrist or hand numbness, minor injection site irritation.

Best for people new to peptide therapy, those with broad wellness goals across sleep, recovery, and gradual body recomposition, and anyone who wants a simple daily protocol with a mild side effect profile.

Ipamorelin/CJC-1295 — The Middle Ground

This is a combination protocol, and the pairing is intentional. CJC-1295 is a GHRH analog that stimulates GH release through the same receptor pathway as sermorelin. Ipamorelin works through a completely different pathway — the ghrelin receptor — and is notable for its selectivity: unlike older secretagogues, it does not significantly raise cortisol or prolactin at therapeutic doses.

Together, they stimulate GH release through two separate mechanisms simultaneously, producing a more robust response than either would alone — and meaningfully stronger than sermorelin. In clinical practice, both are administered as a single combined daily subcutaneous injection, keeping the protocol simple while delivering the synergistic benefit of dual-pathway stimulation.

Sleep and recovery improvements are similar to sermorelin but often more pronounced. Body recomposition is more noticeable. Side effects are moderate — water retention and post-injection flushing are more common than with sermorelin, but cortisol and prolactin remain stable.

Best for patients who want a stronger GH response, those stepping up from sermorelin, and anyone seeking meaningful body recomposition alongside the broader wellness benefits.

Tesamorelin — The High-Intensity Option

Tesamorelin is the full-length GHRH molecule with a structural modification that makes it resistant to the enzyme that normally breaks it down quickly in the body. This gives it a longer duration of action and the most potent GH response of the three.

It is the only peptide in this group with FDA approval — specifically for reducing visceral fat, the dangerous fat that surrounds your internal organs, in a specific patient population. The clinical trials supporting that approval showed IGF-1 increases of 50–100% above baseline and approximately 15% reduction in visceral fat over 26 weeks, confirmed by CT imaging, along with improvements in triglycerides and related metabolic markers.

Dosing is typically daily, though a five-days-on, two-days-off schedule is commonly used in clinical practice to manage water retention. Side effects are the most pronounced of the three — water retention, carpal tunnel-like symptoms from fluid retention, and a small but measurable effect on glucose tolerance in some patients. Monitoring of IGF-1, fasting glucose, and HbA1c is essential throughout treatment.

Best for patients whose primary goal is visceral fat loss, already-fit individuals targeting stubborn midsection fat, and those who want the most aggressive body recomposition results and are prepared for careful monitoring.

A Patient Story

A patient in their late 40s came in frustrated. Consistent training for years, eating well, sleeping reasonably — and still couldn't move the midsection fat or recover the way they used to. Bloodwork was otherwise unremarkable. IGF-1 was in the lower third of the reference range.

We started with ipamorelin/CJC-1295. Within the first month, sleep improved noticeably. By month three, recovery between sessions had shortened and body composition had begun to shift. At six months, they were down several inches at the waist and training harder than they had in a decade.

No shortcuts. The peptide created a more favorable hormonal environment. Consistent training and nutrition did the rest.

How to Choose

Sermorelin is the right starting point if your goals span sleep, recovery, skin, energy, and gradual body composition improvement — or if you're new to injectable peptide therapy and want a gentle introduction. Mildest side effects, simplest daily protocol.

Ipamorelin/CJC-1295 is the step up. Choose this if you want a stronger GH response, more noticeable body recomposition, or if sermorelin didn't deliver the results you were after. Daily combined injection, moderate side effects, dual-pathway stimulation.

Tesamorelin is the high-intensity option. Choose this if visceral fat reduction is your primary goal, you're already doing the lifestyle fundamentals consistently, and you want the most aggressive protocol backed by the strongest clinical evidence. Requires diligent monitoring.

Many patients begin with sermorelin or ipamorelin/CJC-1295 and advance based on their response. Your physician should guide that sequence based on your labs and goals.

What to Expect

Results build progressively. Most patients notice improved sleep and energy within the first two to four weeks. Recovery improvements follow in the first one to three months. Meaningful body composition changes take three to six months of consistent use — don't evaluate results before that three-month mark.

All three protocols require regular monitoring: IGF-1 every three to six months, along with fasting glucose, HbA1c, and thyroid function. These are prescription medications that require physician oversight, not self-directed supplementation.

Ready to Find Out Which Protocol Fits You?

If any of this resonates, the next step is a conversation — not a commitment. At Precision Hormone Consulting, we offer free consultations to review your labs, understand your goals, and determine whether peptide therapy is appropriate and which protocol makes sense for your situation.

You can book a virtual consultation online or call us directly to schedule in person. Either way, you'll leave with a clear picture of where you stand and what your options are.

This article is for educational purposes only and does not constitute medical advice. Growth hormone peptides are prescription medications. Consult a licensed physician before beginning any peptide therapy protocol.